Adu PA; Rossi C; Binka M; Wong S; Wilton J; Wong J; Butt ZA; Bartlett S; Jeong D; Pearce M; Darvishian M; Yu A; Alvarez M; Velásquez García HA; Krajden M; Janjua NZ, 2021, 'HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men', Liver International, vol. 41, pp. 482 - 493, http://dx.doi.org/10.1111/liv.14762
Bartlett SR; Buxton J; Palayew A; Picchio CA; Janjua NZ; Kronfli N, 2021, 'Hepatitis C Virus Prevalence, Screening, and Treatment Among People Who Are Incarcerated in Canada: Leaving No One Behind in the Direct-Acting Antiviral Era', Clinical Liver Disease, vol. 17, pp. 75 - 80, http://dx.doi.org/10.1002/cld.1023
Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M, 2021, '"The Times They Are a-Changin'": Addressing Common Misconceptions About the Role of Safe Supply in North America's Overdose Crisis', Journal of studies on alcohol and drugs, vol. 82, pp. 158 - 160, http://dx.doi.org/10.15288/jsad.2021.82.158
Samji H; Yu A; Wong S; Wilton J; Binka M; Alvarez M; Bartlett S; Pearce M; Adu P; Jeong D; Clementi E; Butt Z; Buxton J; Gilbert M; Krajden M; Janjua NZ, 2020, 'Drug-related deaths in a population-level cohort of people living with and without hepatitis C virus in British Columbia, Canada', International Journal of Drug Policy, vol. 86, http://dx.doi.org/10.1016/j.drugpo.2020.102989
Pearce ME; Yu A; Alvarez M; Bartlett SR; Binka M; Jeong D; Clementi E; Adu P; Wilton J; Yoshida EM; Pick N; Buxton JA; Wong J; Jassem A; Krajden M; Janjua NZ, 2020, 'Prenatal hepatitis C screening, diagnoses, and follow-up testing in British Columbia, 2008–2019', PLoS ONE, vol. 15, http://dx.doi.org/10.1371/journal.pone.0244575
Clementi E; Bartlett S; Otterstatter M; Buxton JA; Wong S; Yu A; Butt ZA; Wilton J; Pearce M; Jeong D; Binka M; Adu P; Alvarez M; Samji H; Abdia Y; Wong J; Krajden M; Janjua NZ, 2020, 'Syndemic profiles of people living with hepatitis C virus using population-level latent class analysis to optimize health services', International Journal of Infectious Diseases, vol. 100, pp. 27 - 33, http://dx.doi.org/10.1016/j.ijid.2020.08.035
Martinello M; Yee J; Bartlett SR; Read P; Baker D; Post JJ; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Lin L; Marks P; Applegate T; Dore GJ; Matthews GV, 2020, 'Moving towards Hepatitis C microelimination among people living with human immunodeficiency virus in Australia: The CEASE study', Clinical Infectious Diseases, vol. 71, pp. 1502 - 1510, http://dx.doi.org/10.1093/cid/ciz985
Bonn M; Palayew A; Bartlett S; Brothers TD; Touesnard N; Tyndall M, 2020, 'Addressing the syndemic of hiv, hepatitis c, overdose, and covid-19 among people who use drugs: The potential roles for decriminalization and safe supply', Journal of Studies on Alcohol and Drugs, vol. 81, pp. 556 - 560, http://dx.doi.org/10.15288/jsad.2020.81.556
Wilton J; Wong S; Yu A; Ramji A; Cook D; Butt ZA; Alvarez M; Binka M; Darvishian M; Jeong D; Bartlett SR; Pearce ME; Adu PA; Yoshida EM; Krajden M; Janjua NZ, 2020, 'Real-world effectiveness of sofosbuvir/velpatasvir for treatment of chronic Hepatitis C in British Columbia, Canada: A population-based cohort study', Open Forum Infectious Diseases, vol. 7, http://dx.doi.org/10.1093/ofid/ofaa055
Darvishian M; Wong S; Binka M; Yu A; Ramji A; Yoshida EM; Wong J; Rossi C; Butt ZA; Bartlett S; Pearce ME; Samji H; Cook D; Alvarez M; Chong M; Tyndall M; Krajden M; Janjua NZ, 2020, 'Loss to follow-up: A significant barrier in the treatment cascade with direct-acting therapies', Journal of Viral Hepatitis, vol. 27, pp. 243 - 260, http://dx.doi.org/10.1111/jvh.13228
Bajis S; Grebely J; Hajarizadeh B; Applegate T; Marshall AD; Ellen Harrod M; Byrne J; Bath N; Read P; Edwards M; Gorton C; Hayllar J; Cock V; Peterson S; Thomson C; Weltman M; Jefferies M; Wood W; Haber P; Ezard N; Martinello M; Maher L; Dore GJ; Peolim L; How-Chow D; Telenta J; Harvey P; Jones S; Dunlop A; Treloar C; Samuel Y; Poeder F; Crawford S; Baxter A; Keats J; Mowat Y; Silk D; Micallef M; Tamaddoni M; Marks P; Lamoury F; Jayasinghe I; Reid H; Cunningham EB; Bartlett S; Jacka B; Erratt A; Jauncey M; Collie P; Lam T; Gilliver R; Hazelwood S; Houlihan N; Burns C; Lewis R; Morris D; Donohue K; Carthew A; Horasak N; Cherry R; Shin S; Peterson D; Sellwood T; McKeown W; Pritchard-Jones J; Smyth F; Adey S; Clark K, 2020, 'Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre- and post-universal access to direct-acting antiviral treatment in Australia: The LiveRLife study', Journal of Viral Hepatitis, vol. 27, pp. 281 - 293, http://dx.doi.org/10.1111/jvh.13233
Bartlett SR; Yu A; Chapinal N; Rossi C; Butt Z; Wong S; Darvishian M; Gilbert M; Wong J; Binka M; Alvarez M; Tyndall M; Krajden M; Janjua NZ, 2019, 'The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals', Liver International, vol. 39, pp. 2261 - 2272, http://dx.doi.org/10.1111/liv.14227
Rossi C; Jeong D; Wong S; McKee G; Butt ZA; Buxton J; Wong J; Darvishian M; Bartlett S; Samji H; Yu A; Binka M; Alvarez M; Adu PA; Tyndall M; Krajden M; Janjua NZ, 2019, 'Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations', Journal of Hepatology, vol. 71, pp. 1116 - 1125, http://dx.doi.org/10.1016/j.jhep.2019.07.021
Bartlett S; Krajden M; Janjua N; Buller-Taylor T, 2019, 'Using population-level integrated health data to monitor and assess patients’ progression across care and treatment continuums', British Columbia Medical Journal, vol. 61, pp. 78 - 80
Bartlett SR; Applegate TL; Jacka BP; Martinello M; Lamoury FMJ; Danta M; Bradshaw D; Shaw D; Lloyd AR; Hellard M; Dore GJ; Matthews GV; Grebely J, 2019, 'A latent class approach to identify multi-risk profiles associated with phylogenetic clustering of recent hepatitis C virus infection in Australia and New Zealand from 2004 to 2015', Journal of the International AIDS Society, vol. 22, pp. e25222, http://dx.doi.org/10.1002/jia2.25222
Bartlett SR; Fox P; Cabatingan H; Jaros A; Gorton C; Lewis R; Priscott E; Dore GJ; Russell DB, 2018, 'Demonstration of near-elimination of Hepatitis C virus among a prison population: The Lotus Glen Correctional Centre Hepatitis C Treatment Project', Clinical Infectious Diseases, vol. 67, pp. 460 - 463, http://dx.doi.org/10.1093/cid/ciy210
Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe AYM; Miller V; Ceccherini-Silberstein F; Bull RA; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky J-M; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Sequencing of Hepatitis C Virus for Detection of Resistance to Direct-Acting Antiviral Therapy: A Systematic Review', HEPATOLOGY COMMUNICATIONS, vol. 1, pp. 379 - 390, http://dx.doi.org/10.1002/hep4.1050
Bartlett SR; Wertheim JO; Bull RA; Matthews GV; Lamoury FMJ; Scheffler K; Hellard M; Maher L; Dore GJ; Lloyd AR; Applegate TL; Grebely J, 2017, 'A molecular transmission network of recent hepatitis C infection in people with and without HIV: Implications for targeted treatment strategies', Journal of Viral Hepatitis, vol. 24, pp. 404 - 411, http://dx.doi.org/10.1111/jvh.12652
Bartlett SR; Jacka B; Bull RA; Luciani F; Matthews GV; Lamoury FMJ; Hellard ME; Hajarizadeh B; Teutsch S; White B; Maher L; Dore GJ; Lloyd AR; Grebely J; Applegate TL, 2016, 'HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infection', Infection, Genetics and Evolution, vol. 37, pp. 252 - 258, http://dx.doi.org/10.1016/j.meegid.2015.11.028
Lamoury FMJ; Jacka B; Bartlett S; Bull RA; Wong A; Amin J; Schinkel J; Poon AF; Matthews GV; Grebely J; Dore GJ; Applegate TL, 2015, 'The influence of hepatitis C virus genetic region on phylogenetic clustering analysis', PLoS ONE, vol. 10, http://dx.doi.org/10.1371/journal.pone.0131437
Lamoury FMJ; Bartlett S; Jacka B; Hajarizadeh B; Grebely J; Matthews GV; Dore GJ; Applegate TL, 2015, 'Interferon λ 3 and 4 genotyping using high-resolution melt curve analysis suitable for multiple clinical sample types', Journal of Molecular Diagnostics, vol. 17, pp. 583 - 589, http://dx.doi.org/10.1016/j.jmoldx.2015.05.003
Bartlett SR; Seeliger J; Burnell JN, 2012, 'Identification of critical residues in the bifunctional phosphoenolpyruvate synthetase kinase/phosphotransferase of Escherichia coli', Current Topics in Biochemical Research, vol. 14, pp. 77 - 83
Bartlett S; Wong S; Alvarez M; Buller-Taylor T; Butt Z; Darvishian M; Rossi C; Pearce M; Wong J; Mark G; Mark T; Krajden M; Janjua N, 2019, 'Integrating health and administrative datasets to improve quality of care: The BC-HTC', Vancouver, Canada, presented at British Columbia Quality Forum 2019, Vancouver, Canada, 26 February 2019 - 28 February 2019
Hooshyar SH; Martinello M; Yee J; Bartlett S; Read P; Baker D; Post J; Finlayson R; Bloch M; Doyle J; Shaw D; Hellard M; Petoumenos K; Marks P; Applegate T; Dore G; Matthew G, 2019, 'Low HCV reinfection incidence following DAA treatment scale-up in people living with HIV in Australia', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E734 - E734, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703225&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Bartlett S; Wong S; Yu A; Alvarez M; Buller-Taylor T; Butt ZA; Darvishian M; Rossi C; Binka M; Pearce M; JasonWong D; Gilbert M; Tyndall M; Krajden M; Janjua N, 2019, 'Factors associated with hepatitis C treatment uptake among people who inject drugs in a population based data linkage study', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E210 - E211, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30393-7
Janjua N; Wong S; Rossi C; Darvishian M; Yu A; Butt ZA; Yoshida E; Ramji A; Feld J; Binka M; Bartlett S; Pearce M; Alvarez M; Samji H; Tyndall M; Krajden M, 2019, 'The impact of SVR from direct acting antiviral and interferon-based treatments for HCV on hepatocellular carcinoma risk in a large population based cohort', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E736 - E736, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000463481703228&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
Darvishian M; Rossi C; Wong S; Yu A; Woods R; Binka M; Butt ZA; Buxton J; Bartlett S; Pearce M; Wong J; Gilbert M; Grennan T; Alvarez M; Cook D; Yoshida E; Spinelli J; Tyndall M; Krajden M; Janjua N, 2019, 'Cancer risk among people with HIV, HBV, and/or HCV infections', in JOURNAL OF HEPATOLOGY, ELSEVIER, Vienna, AUSTRIA, Vol. 70, pp. E328 - E329, presented at International Liver Congress / 54th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), Vienna, AUSTRIA, 10 April 2019 - 14 April 2019, http://dx.doi.org/10.1016/S0618-8278(19)30642-5
Martinello M; Bartlett S; Dore G; Bopage R; Finlayson R; Baker D; Bloch M; Doyle J; Shaw D; Hajkowicz K; Read P; Filep E; Lin L; Yee J; Applegate T; Hellard M; Matthews G, 2018, 'Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia', in Universal access to DAA therapy paves the way for HCV control and elimination among people living with HIV in Australia, Paris, France, presented at THE INTERNATIONAL LIVER CONGRESS 2018, Paris, France, 11 April 2018 - 15 April 2018
Bartlett SR; Grebely J; Eltahla AA; Reeves JD; Howe A; Miller V; Bull RA; Ceccherini-Silberstein F; Douglas MW; Dore GJ; Harrington P; Lloyd AR; Jacka B; Matthews GV; Wang GP; Pawlotsky J-M; Feld JJ; Schinkel J; Garcia F; Lennerstrand J; Applegate TL, 2017, 'Systematic review & expert guidance on methods for sequencing of hepatitis C virus for detection of direct-acting antiviral resistance', in JOURNAL OF HEPATOLOGY, ELSEVIER SCIENCE BV, Amsterdam, NETHERLANDS, Vol. 66, pp. S323 - S323, presented at International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver, Amsterdam, NETHERLANDS, 19 April 2017 - 23 April 2017, http://dx.doi.org/10.1016/S0168-8278(17)30970-4
Bartlett SR, 2017, Molecular epidemiology of recently acquired hepatitis C virus infection in Australia
